(99m)Tc-MIP-1427

N/A

Report date: 2025/11/20 16:02:32

NME

Base Information

Drug Name(99m)Tc-MIP-1427

Drug Alias Name(99m)Tc-MIP-142799mTc-MIP-1427

ClassificationRadiation-emitting products > Nuclides > Technetium > 99mTcRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesGermany

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesMolecular Insight Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesHeidelberg University Hospital Molecular Insight Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A